Castle Biosciences CSTL
NASDAQ CSTL
$34.24 +0.15 (+0.45%)
As of: Aug 27, 2026 · 3:59 PM EDT

Castle Biosciences (CSTL) Non Operating Investment Income (2025 - 2026)

Castle Biosciences (CSTL) posted Non Operating Investment Income of -$630000.0 for Q2 2026, down 131.16% sequentially from $2.0 million in Q1 2026, and down 153.16% YoY from $1.2 million in Q2 2025.

Castle Biosciences (CSTL) Non Operating Investment Income (2025 - 2026) Analysis & Trends

Castle Biosciences has reported Non Operating Investment Income for 2 years, with the latest figure at -$630000.0 in Q2 2026.

  • Quarterly Non Operating Investment Income fell 153.16% year-over-year to -$630000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.2 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, up 164.14% from the prior year.
  • Non Operating Investment Income declined to -$630000.0 in Q2 2026 per CSTL's latest filing, from $2.0 million in the prior quarter.
  • Over five years, Non Operating Investment Income peaked at $2.0 million in Q1 2026 and troughed at -$1.4 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn -
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 Castle Biosciences 1.04 Bn 773.13 Mn 79.85 Mn -630,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -630,000.00
Jun 30, 2026 -630,000.00
Mar 31, 2026 2.02 Mn
Mar 31, 2026 2.02 Mn
Jun 30, 2025 1.19 Mn
Jun 30, 2025 1.19 Mn
Mar 31, 2025 -1.43 Mn
Mar 31, 2025 -1.43 Mn